Quebec Public Health National Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02009800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Quebec Public Health Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Papillomavirus Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2